Skip to main content

Table 2 The distribution of molecular markers.

From: Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Molecular markers

N

P21

 

   -

28

   +

29

   ++

43

   +++

22

CD44/v6

 

   -

72

   +

27

   ++

20

   +++

3

EGFR

 

   -

71

   +

27

   ++

16

   +++

8

Neu

 

   -

81

   +

26

   ++

12

   +++

3

P53

 

   -

45

   +

27

   ++

27

   +++

23

PCNA

 

   <= 50%

32

   >50%

90

Total

122

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us